Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
01 07 2021
Historique:
received: 28 06 2020
accepted: 30 11 2020
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 13 7 2021
Statut: epublish

Résumé

Emergent pathogen as Purpureocillium lilacinum are becoming cause of morbidity and mortality in our population, especially in immunocompromised patients. We describe a case of hyalohyphomycosis in a diabetic man under systemic steroid treatment for a bullous pemphigoid. Treatment with different antimycotic drugs were ineffective and infection spread diffusely, leading to deterioration of general conditions and ultimately death. The aim of this article is to increase awareness of clinicians about this uncommon, but frequently fatal refractory mycotic infection.

Identifiants

pubmed: 34212928
doi: 10.23750/abm.v92i3.10100
pmc: PMC8343759
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2021139

Références

Antimicrob Agents Chemother. 2013 Nov;57(11):5271-6
pubmed: 23939898
Eur J Clin Microbiol Infect Dis. 1999 Nov;18(11):814-8
pubmed: 10614958
Antimicrob Agents Chemother. 2008 Aug;52(8):2926-8
pubmed: 18519716
Clin Microbiol Infect. 2006 Oct;12(10):948-60
pubmed: 16961630
N Engl J Med. 2014 Jul 10;371(2):150-60
pubmed: 25006721

Auteurs

Marialuisa Corbeddu (M)

Unit of Dermatology, Department of Medical Science and Public Health, University of Cagliari. marialuisa.corbeddu@gmail.com.

Caterina Ferreli (C)

Unit of Dermatology, Department of Medical Science and Public Health, University of Cagliari. ferreli@unica.it.

Riccardo Cappai (R)

Laboratory Clinical Chemical Analysis and Microbiology University Hospital of Cagliari. riccardo.cappai.posta@gmail.com.

Patrizia Ferraguti (P)

Laboratory Clinical Chemical Analysis and Microbiology University Hospital of Cagliari. pferraguti@aoucagliari.it.

Laura Atzori (L)

Unit of Dermatology, Department of Medical Science and Public Health, University of Cagliari. atzoril@unica.it.

Luca Pilloni (L)

Unit of Pathology, Department of Medical Science and Public Health, University of Cagliari. lucpilloni@tiscali.it.

Franco Rongioletti (F)

Unit of Dermatology, Department of Medical Science and Public Health, University of Cagliari. rongioletti@unica.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH